StocksIncyte Corp.INCY

INCY

Incyte Corp.

76.51 1.40 (1.86%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
76.46
B
76.61

Overview

Prev Close76.51
Day's Range 74.66 - 76.71
52 Week Range 61.84 - 88.09
Average Volume (3m)1.44M
1-Year Return-7.42%
Beta0.6446
Market Cap16.64B
P/E Ratio17.88
Revenue3.11B
EPS4.2006
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.714/12/202124/02/202206/05/202265.0070.0075.0080.0085.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Herve Hoppenot
Employees 2,094

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, Incyte Corp.'s revenues decreased by 15.02% and amounted to 733.24M. Net income decreased by 93.26% to 37.99M. Net assets decreased by NaN to 3.86B and EPS decreased from N/A to 0.17.
INCY's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
93.47%
Net Profit Margin
5.36%
Operating Margin
20.88%
Return On Investment
3.45%
06/21
09/21
12/21
03/22
Total Revenue
705.71M
812.99M
862.85M
733.24M
Gross Profit
673.07M
778.5M
824.36M
679.58M
Operating Income
N/A
N/A
N/A
127.66M
Net Income
149.46M
181.74M
563.85M
37.99M